Anuh Pharma Limited receives EDQM approval for CEP of Azithromycin API

Anuh Pharma Limited has announced a successful accomplishment, wherein the company has received approval from EDQM for CEP of Azithromycin API which is a Broad Spectrum Macrolide Antibiotic.

Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 101.85 as compared to the previous close of Rs. 102.75. The total number of shares traded during the day was 24192 in over 346 trades.

The stock hit an intraday high of Rs. 104.50 and intraday low of 101.00. The net turnover during the day was Rs. 2477445.00.

Source : Equity Bulls

Keywords

ANUHPHARMA INE489G01022 EDQM Approval CEP AzithromycinAPI